Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens

Journal of Internal Medicine

Volumn 252, Issue 4, 2002, Pages 352-360

  Harsch, I A ^a   Stocker, S ^b   Radespiel Troger M ^a   Hahn, E G ^a   Konturek, P C ^a   Ficker, J H ^a   Lohmann, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b KLINIKUM FÜRTH   (Germany)

Author keywords

Accidents; Diabetes mellitus; Hypoglycaemia; Insulin therapy; Sulphonylureas

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLISOXEPIDE; METFORMIN; REPAGLINIDE; SULFONYLUREA DERIVATIVE;

ACCIDENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STATISTICAL ANALYSIS; TRAFFIC SAFETY;

ACCIDENTS, TRAFFIC; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DATA INTERPRETATION, STATISTICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RESEARCH DESIGN;

EID: 0036032961     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01048.x     Document Type: Article

References (26)

1. Ysander L. The safety of drivers with chronic disease. Br J Ind Med 1966; 23: 28-36.
2. Herner B, Smedby B, Ysander L. Sudden illness as a cause of motor-vehicle accidents. Br J Ind Med 1966; 23: 37-41.
3. Ysander L. Sick and handicapped drivers. A study on the risks of sudden illness at the wheel and on the frequency of road accidents and traffic offenses in chronically sick, disabled and elderly drivers. Acta Chir Scand 1970; 409: 1-27 (Suppl.).
4. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance. Diabetes Care 2000; 23: 163-70.
5. Lobmann R, Smid HGOM, Pottag G, Wagner K, Heinze H-J, Lehnert H. Impairment and recovery of elementary cognitive function induced by hypoglycemia in type-1 diabetic patients and healthy controls. J Clin Endocrinol Metab 2000; 85: 2758-66.
6. Waller JA. Chronic medical conditions and traffic safety: Review of the California experience. New Engl J Med 1965; 273: 1413-20.
7. Crancer A, Mc Murray L. Accident and violation rates of Washington's medically restricted drivers. JAMA 1968; 205: 74-8.
8. Davis TG, Wehling EH, Carpenter RL. Oklahoma's medically restricted drivers. A study of selected medical conditions. Oklahoma State Med Ass J 1973; 66: 322-7.
9. Eadington DW, Frier BM. Type I diabetes and driving experience: an eight year cohort study. Diabet Med 1989; 6: 137-41.
10. Chantelau E, Dannbeck S, Kimmerle R, Ross D. Zur verkehrstüchtigkeit insulin-behandelter diabetiker. MMW 1990; 132: 468-71.
11. Distiller LA, Kramer BD. Driving and diabetics on insulin therapy. South African Med J 1986; 86: 1018-20.
12. Stevens AB, Roberts M, McKane R, Atkinson AB, Bell PM, Hayes JR. Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ 1989; 299: 591-5.
13. Hansotia P, Broste SK. The effect of epilepsy or diabetes mellitus on the risk of automobile accidents. New Engl J Med 1991; 324: 22-6.
14. Mathiesen B, Borch-Johnsen K. Diabetes and accident insurance. A 3-year follow-up of 7599 insured diabetic individuals. Diabetes Care 1997; 20: 1781-4.
15. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
16. Okhubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diab Res Clin Pract 1995; 28: 103-17.
17. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
18. American Diabetes Association. Implications of the United Kingdom prospective diabetes study (Position statement). Diabetes Care 1998; 21: 2180-4.
19. Cassel W, Ploch T, Becker C, Dugnus D, Peter JH, von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: Reduction with nasal CPAP. Eur Respir J 1996; 9: 2606-11.
20. Pramming S, Thorsteinsson B, Bendtson I, Binder C. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med 1990; 228: 641-6.
21. Fritsche A, Stefan N, Haring H, Gerich J, Sturmvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001; 134: 729-36.
22. Gold AE, Mac Leod KM, Frier BM. Frequency of severe hypoglycemia im patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
23. Cox D, Clarke W, Gonder-Frederick L, Kovatchev B. Driving mishaps and hypoglycemia: risk and prevention. Int J Clin Pract 2001; 123: 38-42 (Suppl.).
24. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the united states: Quality of care in the 1990s. Ann Intern Med 2002; 136: 565-74.
25. Clarke WL, Cox DJ, Gonder-Frederick LA, Kovatchev BP. Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes. JAMA 1999; 282: 750-4.
26. Barry-Bianchi S. 'Real-Life' driving behavior while hypoglycemic. Diabetes Care 2000; 23: 1210-1.